AFT:NZE
AFT Pharmaceuticals Ltd
NZ$4.35
arrow_downward
-0.91%(-0.040) 1D
Sep 28, 4:44:44 PM GMT+13 · NZD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AFT...
Open
NZ$4.42
High
NZ$4.48
Low
NZ$4.35
Mkt. cap
460.40M
Avg. vol.
28.75K
Volume
23.40K
Dividend
0.57%
Quarterly dividend
NZ$0.01
Ex-dividend date
Jun 18, 2026
P/E ratio
30.97
52-wk high
NZ$4.85
52-wk low
NZ$2.74
EPS
NZ$0.14
Shares outstanding
104.87M
No. of employees
126
Open
NZ$4.42
High
NZ$4.48
Low
NZ$4.35
Mkt. cap
460.40M
Avg. vol.
28.75K
Volume
23.40K
Dividend
0.57%
Quarterly dividend
NZ$0.01
Ex-dividend date
Jun 18, 2026
P/E ratio
30.97
52-wk high
NZ$4.85
52-wk low
NZ$2.74
EPS
NZ$0.14
Shares outstanding
104.87M
No. of employees
126
News stories
From web sources and news partners
TipRanks
·
20 hours ago
AFT Pharmaceuticals licenses Maxigesic IV to Mikasa for Japanese market push
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees126
Founded1997
Headquarters-
SectorPharmaceutical industry
Websiteaftpharm.com